Trial intelligence / Profile preview

Metformin to extend diabetes remission after bariatric surgery

2019-000312-28Phase 3Active

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Oct 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Started Oct 2019; status: active.

02

Drugs

metformin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on 2019-000312-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2019-000312-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call